8-KEarnings & ResultsRegulation FDOther Events+1

METLIFE INC 8-K Report, Financial Results (Feb 2, 2022)

Filed February 2, 2022For Securities:METMET-PEMET-PFMET-PA

Summary

MetLife, Inc. filed an 8-K on February 2, 2022, primarily to furnish its fourth-quarter and full-year 2021 earnings release, quarterly financial supplement, and supplemental slides. While the filing does not contain specific financial results within the 8-K itself, it outlines the company's outlook and strategic positioning. Investors can glean insights into MetLife's financial health and future expectations by reviewing the attached exhibits. The company is emphasizing its robust liquidity position, with holding company cash significantly exceeding its target range. MetLife also reiterated its commitment to its Next Horizon Strategy and provided financial targets for key metrics such as free cash flow to adjusted earnings ratio and adjusted return on equity, assuming specific interest rate and market conditions. The outlook acknowledges the ongoing uncertainties related to the COVID-19 pandemic, with plans to continuously review assumptions and implement mitigation strategies.

Key Highlights

  • 1MetLife furnished its Q4 and Full Year 2021 earnings release, quarterly financial supplement, and supplemental slides, providing detailed financial results and outlook.
  • 2The company maintains a strong liquidity position with $5.4 billion in holding company cash, exceeding its $3.0 billion to $4.0 billion target range.
  • 3MetLife expects to maintain its holding company cash target at or above the high end of the range in 2022.
  • 4The company targets a free cash flow to adjusted earnings ratio of 65% to 75% over the near-term, based on specific economic assumptions.
  • 5MetLife continues to target an adjusted return on equity (excluding AOCI other than FX) of 12% to 14% over the near-term.
  • 6The company is on track to generate approximately $20.0 billion of free cash flow between 2020 and 2024.
  • 7MetLife is committed to achieving a full-year direct expense ratio of less than 12.3% over the near-term, excluding specific items.

Frequently Asked Questions